Baricitinib for treatment of ustekinumab-induced paradoxical eczematous reactions in a patient with plaque psoriasis.
Shobatake C, Miyagawa F, Mitsui Y, Nakanishi Y, Ogawa K, Asada H
European Journal of DermatologyIn the feed 27 Jul 2026, issue 2026 Jun 01, added to PubMed 27 Jul 2026
Topics: PsoriasisAtopic dermatitis & eczemaBiologicsJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42507402 · DOI 10.1684/ejd.2026.5077